.
jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies..fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and...
![]()
.
.(soundbite of les pommes de ma douche's "trompettes de la renommee") transcript provided by npr, copyright npr..